You have 9 free searches left this month | for more free features.

SR 46349B

Showing 1 - 25 of 7,506

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed or Refractory B-cell Lymphoma Trial in Shanghai (SR-GDP)

Not yet recruiting
  • Relapsed or Refractory B-cell Lymphoma
  • Shanghai, Shanhai, China
    Ruijin Hospital
Sep 29, 2023

Attention Deficit Disorder With Hyperactivity Trial in United States (CTN SR, Matching )

Completed
  • Attention Deficit Disorder With Hyperactivity
  • CTN SR
  • Matching placebo
  • Newport Beach, California
  • +3 more
Oct 14, 2021

Influenza A Trial in United States (LD Sing2016 M2SR H3N2 influenza vaccine, MD Sing2016 M2SR H3N2 influenza vaccine, HD

Completed
  • Influenza A
  • LD Sing2016 M2SR H3N2 influenza vaccine
  • +4 more
  • Hollywood, Florida
  • +3 more
Dec 10, 2021

Influenza Vaccine Trial in United States (Cam2020 M2SR H3N2 influenza vaccine, Fluzone HD IIV, IN Placebo)

Completed
  • Influenza Vaccine
  • Cam2020 M2SR H3N2 influenza vaccine
  • +3 more
  • Port Orange, Florida
  • +5 more
Nov 11, 2022

Lyme Disease Trial in United States (mRNA-1975, mRNA-1982, Placebo)

Recruiting
  • Lyme Disease
  • mRNA-1975
  • +2 more
  • Milford, Connecticut
  • +19 more
Jul 26, 2023

Influenza Vaccine Trial in Anaheim, DeLand, Lenexa (Sing2016 M2SR H3N2 influenza vaccine, Placebo)

Active, not recruiting
  • Influenza Vaccine
  • Sing2016 M2SR H3N2 influenza vaccine
  • Placebo
  • Anaheim, California
  • +2 more
May 13, 2022

Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD

Recruiting
  • Mucopolysaccharidosis Disorders
  • +28 more
  • Stem Cell Transplantation
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 1, 2022

H3N2 Influenza Trial in United States (Placebo, Sing2016 M2SR H3N2)

Recruiting
  • H3N2 Influenza
  • Placebo
  • Sing2016 M2SR H3N2
  • Iowa City, Iowa
  • +3 more
Mar 10, 2022

Neurogenic Detrusor Overactivity Trial in Brussels (Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B),

Completed
  • Neurogenic Detrusor Overactivity
  • Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B)
  • +4 more
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
Feb 8, 2021

COVID-19 Trial in London (Sample Collection/Performance Evaluation (A), Sample Collection/Performance Evaluation (B))

Suspended
  • COVID-19
  • Sample Collection/Performance Evaluation (A)
  • Sample Collection/Performance Evaluation (B)
  • London, United Kingdom
  • +2 more
Jun 6, 2022

Recurrent DLBCL, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory DLBCL Trial in United States (drug, other, biological)

Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +5 more
  • Duarte, California
  • +3 more
Nov 17, 2022

Wilson Disease Trial in Austin (ALXN1840, Bupropion Hydrochloride)

Completed
  • Wilson Disease
  • Austin, Texas
    Clinical Trial Site
Jul 21, 2021

Pain Trial in Portsmouth, Solihull (Placebo, Pregabalin, Tramadol SR)

Completed
  • Pain
  • Placebo
  • +2 more
  • Portsmouth, Hampshire, United Kingdom
  • +1 more
Jan 20, 2021

Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (Bimatoprost (SR))

Recruiting
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Bimatoprost (SR)
  • Sun City, Arizona
  • +112 more
Aug 16, 2022

Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax

Recruiting
  • Chronic Lymphocytic Leukemia
    • London, London, City Of, United Kingdom
    • +9 more
    Jan 13, 2023

    Caffeine, Insufficient Sleep Trial (Caffeine)

    Not yet recruiting
    • Caffeine
    • Insufficient Sleep
    • (no location specified)
    Mar 16, 2023

    Open-angle Glaucoma, Ocular Hypertension Trial in Japan, United States (AGN-193408 SR, Lumigan, Sham Administration)

    Recruiting
    • Open-angle Glaucoma
    • Ocular Hypertension
    • AGN-193408 SR
    • +3 more
    • Inglewood, California
    • +27 more
    Oct 4, 2022

    Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester

    Not yet recruiting
    • Clinical Stage IV Gastric Cancer AJCC v8
    • +4 more
    • Aldesleukin
    • +10 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Apr 5, 2023

    Point of Care Assay to Identify Phenotypes in Acute Respiratory

    Recruiting
    • Acute Respiratory Distress Syndrome (ARDS)
    • POC Assay
    • Dublin, Ireland
    • +21 more
    Mar 3, 2022

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham: Applicator Without Needle, Active

    Completed
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Bimatoprost SR
    • +3 more
    • Dothan, Alabama
    • +112 more
    Jul 6, 2021

    Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent

    Recruiting
    • Clonal Cytopenia of Undetermined Significance
    • +6 more
    • Ascorbic Acid
    • +12 more
    • Scottsdale, Arizona
    • +4 more
    May 26, 2022

    Acute Ischemic Stroke Trial in Barcelona (Thrombectomy)

    Recruiting
    • Acute Ischemic Stroke
    • Thrombectomy
    • Barcelona, Spain
      Hospital Universitario Vall d'Hebrón
    Nov 18, 2022

    Atrial Fibrillation Prior and Post Elective Cardioversion

    Not yet recruiting
    • Atrial Fibrillation
    • ECG monitoring prior and after cardioversion
    • (no location specified)
    Jun 29, 2023

    Bladder Cancer Trial in Hong Kong (Bipolar transurethral standard resection, Bipolar transurethral en bloc resection)

    Completed
    • Bladder Cancer
    • Bipolar transurethral standard resection
    • Bipolar transurethral en bloc resection
    • Hong Kong, Hong Kong
    • +12 more
    Jun 24, 2022

    Surfactant Dose on Outcomes in Preterm Infants With RDS

    Completed
    • Respiratory Distress Syndrome
    • Bronchopulmonary Dysplasia
      • Ashford, Kent, United Kingdom
      • +28 more
      Feb 18, 2022